| Year |
Citation |
Score |
| 2023 |
Chruścicka-Smaga B, Machaczka A, Szewczyk B, Pilc A. Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies. Pharmacological Reports : Pr. 75: 1341-1349. PMID 37932583 DOI: 10.1007/s43440-023-00547-4 |
0.303 |
|
| 2021 |
Stankiewicz A, Kaczorowska K, Bugno R, Kozioł A, Paluchowska MH, Burnat G, Chruścicka B, Chorobik P, Brański P, Wierońska JM, Duszyńska B, Pilc A, Bojarski AJ. New 1,2,4-oxadiazole derivatives with positive mGlu receptor modulation activity and antipsychotic-like properties. Journal of Enzyme Inhibition and Medicinal Chemistry. 37: 211-225. PMID 34894953 DOI: 10.1080/14756366.2021.1998022 |
0.353 |
|
| 2020 |
Ulivieri M, Wierońska JM, Lionetto L, Martinello K, Cieslik P, Chocyk A, Curto M, Di Menna L, Iacovelli L, Traficante A, Liberatore F, Mascio G, Antenucci N, Giannino G, Vergassola M, ... ... Pilc A, et al. The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia. Schizophrenia Bulletin. PMID 32506121 DOI: 10.1093/Schbul/Sbaa074 |
0.324 |
|
| 2020 |
Burnat G, Brański P, Solich J, Kolasa M, Chruścicka B, Dziedzicka-Wasylewska M, Pilc A. The functional cooperation of 5-HT and mGlu4R in HEK-293 cell line. Pharmacological Reports : Pr. PMID 32472388 DOI: 10.1007/S43440-020-00114-1 |
0.406 |
|
| 2020 |
Kryst J, Kawalec P, Mitoraj AM, Pilc A, Lasoń W, Brzostek T. Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials. Pharmacological Reports. 72: 543-562. PMID 32301056 DOI: 10.1007/S43440-020-00097-Z |
0.34 |
|
| 2019 |
Pałucha-Poniewiera A, Podkowa K, Pilc A. Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats. Behavioural Pharmacology. 30: 471-477. PMID 30724804 DOI: 10.1097/Fbp.0000000000000471 |
0.491 |
|
| 2019 |
Bobula B, Tokarski K, Sowa-Kućma M, Misztak P, Pilc A, Stachowicz K. Effects of acute mGluR7 PAM on changes in short-time plasticity and mGluR7 levels after chronic treatment with mGluR5 antagonist and COX-2 inhibitor European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2018.11.360 |
0.322 |
|
| 2018 |
Cieślik P, Woźniak M, Kaczorowska K, Brański P, Burnat G, Chocyk A, Bobula B, Gruca P, Litwa E, Pałucha-Poniewiera A, Wąsik A, Pilc A, Wierońska J. Negative Allosteric Modulators of mGlu Receptor as Putative Antipsychotic Drugs. Frontiers in Molecular Neuroscience. 11: 316. PMID 30294258 DOI: 10.3389/Fnmol.2018.00316 |
0.429 |
|
| 2018 |
Cieślik P, Woźniak M, Tokarski K, Kusek M, Pilc A, Płoska A, Radulska A, Pelikant-Małecka I, Żołnowska B, Sławiński J, Kalinowski L, Wierońska JM. Simultaneous activation of muscarinic and GABA receptors as a bidirectional target for novel antipsychotics. Behavioural Brain Research. 359: 671-685. PMID 30267715 DOI: 10.1016/j.bbr.2018.09.019 |
0.314 |
|
| 2018 |
Wierońska JM, Pilc A. Depression and schizophrenia viewed from the perspective of amino acidergic neurotransmission: Antipodes of psychiatric disorders. Pharmacology & Therapeutics. PMID 30149102 DOI: 10.1016/J.Pharmthera.2018.08.010 |
0.363 |
|
| 2018 |
Podkowa K, Pilc A, Podkowa A, Sałat K, Marciniak M, Pałucha-Poniewiera A. The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice. Neuropharmacology. PMID 30145321 DOI: 10.1016/j.neuropharm.2018.08.022 |
0.344 |
|
| 2018 |
Ryszewska-Pokraśniewicz B, Mach A, Skalski M, Januszko P, Wawrzyniak ZM, Poleszak E, Nowak G, Pilc A, Radziwoń-Zaleska M. Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response. Nutrients. 10. PMID 30081500 DOI: 10.3390/Nu10081014 |
0.327 |
|
| 2017 |
Pałucha-Poniewiera A, Podkowa K, Lenda T, Pilc A. The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 79: 155-161. PMID 28647535 DOI: 10.1016/J.Pnpbp.2017.06.022 |
0.388 |
|
| 2017 |
Chilmonczyk Z, Bojarski AJ, Pilc A, Sylte I. Serotonin transporter and receptor ligands with antidepressant activity as neuroprotective and proapoptotic agents. Pharmacological Reports. 69: 469-478. PMID 28324844 DOI: 10.1016/J.Pharep.2017.01.011 |
0.364 |
|
| 2017 |
Woźniak M, Gołembiowska K, Noworyta-Sokołowska K, Acher F, Cieślik P, Kusek M, Tokarski K, Pilc A, Wierońska JM. Neurochemical and behavioral studies on the 5-HT1A-dependent antipsychotic action of the mGlu4 receptor agonist LSP4-2022. Neuropharmacology. 115: 149-165. PMID 27465045 DOI: 10.1016/J.Neuropharm.2016.06.025 |
0.408 |
|
| 2017 |
Ciešlik P, Woźniak M, Pilc A, Wierońska J. The involvement of GABAB receptors in antipsychotic-like effects of positive allosteric modulator of muscarinic acetylcholine M4 receptors European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31703-0 |
0.415 |
|
| 2017 |
Bobula B, Hess G, Pańczyszyn-Trzewik P, Misztak P, Sowa-Kucma M, Nowak G, Pilc A, Stachowicz K. The effects of co-administration MTEP antagonist and NS-398 on synaptic plasticity in the frontal cortex and hippocampus of mice European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31416-5 |
0.301 |
|
| 2017 |
Stachowicz K, Sowa-Kucma M, Pańczyszyn-Trzewik P, Misztak P, Nowak G, Pilc A. Chronic co-administration of mGluR5 antagonist (MTEP) with COX-2 inhibitor (NS398) affects DSCAM expression in prefrontal cortex and hippocampus in C57Bl/6J mice European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31407-4 |
0.307 |
|
| 2017 |
Podkowa K, Podkowa A, Sałat K, Pilc A, Pałucha-Poniewiera A. AMN082, a positive allosteric modulator of the mGlu7 receptor, enhances the antidepressant-like activity of scopolamine in the tail suspension test European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)31248-8 |
0.422 |
|
| 2017 |
Pańczyszyn-Trzewik P, Misztak P, Sowa-Kućma M, Szewczyk B, Nowak G, Pilc A, Stachowicz K. Co-administration of COX-2 inhibitor NS-398 enhances antidepressant effect of mGluR5 antagonist MTEP in mice European Neuropsychopharmacology. 27. DOI: 10.1016/S0924-977X(17)30077-9 |
0.347 |
|
| 2016 |
Podkowa K, Podkowa A, Sałat K, Lenda T, Pilc A, Pałucha-Poniewiera A. Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495. Neuropharmacology. PMID 27569995 DOI: 10.1016/J.Neuropharm.2016.08.031 |
0.485 |
|
| 2016 |
Pałucha-Poniewiera A, Pilc A. Glutamate-Based Drug Discovery for Novel Antidepressants. Expert Opinion On Drug Discovery. PMID 27409299 DOI: 10.1080/17460441.2016.1213234 |
0.357 |
|
| 2016 |
Podkowa K, Pochwat B, Brański P, Pilc A, Pałucha-Poniewiera A. Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats. Psychopharmacology. PMID 27286960 DOI: 10.1007/s00213-016-4325-7 |
0.385 |
|
| 2016 |
Rzezniczek S, Obuchowicz M, Datka W, Siwek M, Dudek D, Kmiotek K, Oved K, Shomron N, Gurwitz D, Pilc A. Decreased sensitivity to paroxetine-induced inhibition of peripheral blood mononuclear cell growth in depressed and antidepressant treatment-resistant patients Translational Psychiatry. 6. PMID 27244236 DOI: 10.1038/Tp.2016.90 |
0.323 |
|
| 2016 |
Woźniak M, Acher F, Marciniak M, Lasoń-Tyburkiewicz M, Gruca P, Papp M, Pilc A, Wierońska JM. Involvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022. Current Neuropharmacology. 14: 413-426. PMID 26769224 DOI: 10.2174/1570159X13666150516000630 |
0.446 |
|
| 2016 |
Wieronska JM, Woźniak M, Cieślik P, Pilc A. The antipsychotic-like activity of VU152100, a muscarinic M4 receptor positive allosteric modulator, in animal models of schizophrenia European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31563-2 |
0.339 |
|
| 2016 |
Pałucha-Poniewiera A, Podkowa K, Pilc A. Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of scopolamine in behavioural models of depression European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31094-X |
0.428 |
|
| 2015 |
Wierońska JM, Zorn SH, Doller D, Pilc A. Metabotropic glutamate receptors as targets for new antipsychotic drugs: Historical perspective and critical comparative assessment. Pharmacology & Therapeutics. PMID 26549541 DOI: 10.1016/J.Pharmthera.2015.10.007 |
0.395 |
|
| 2015 |
Chilmonczyk Z, Bojarski AJ, Pilc A, Sylte I. Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands. International Journal of Molecular Sciences. 16: 18474-506. PMID 26262615 DOI: 10.3390/ijms160818474 |
0.308 |
|
| 2015 |
Podkowa K, Rzeźniczek S, Marciniak M, Acher F, Pilc A, Pałucha-Poniewiera A. A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action. Neuropharmacology. 97: 338-45. PMID 26074092 DOI: 10.1016/j.neuropharm.2015.05.039 |
0.376 |
|
| 2015 |
Jantas D, Greda A, Leskiewicz M, Grygier B, Pilc A, Lason W. Neuroprotective effects of mGluR II and III activators against staurosporine- and doxorubicin-induced cellular injury in SH-SY5Y cells: New evidence for a mechanism involving inhibition of AIF translocation. Neurochemistry International. PMID 25661514 DOI: 10.1016/J.Neuint.2014.12.011 |
0.315 |
|
| 2015 |
Chru?cicka B, Burnat G, Bra?ski P, Chorobik P, Lenda T, Marciniak M, Pilc A. Tetracycline-based system for controlled inducible expression of group III metabotropic glutamate receptors. Journal of Biomolecular Screening. 20: 350-8. PMID 25394730 DOI: 10.1177/1087057114559183 |
0.427 |
|
| 2015 |
Wiero?ska JM, S?awi?ska A, ?aso?-Tyburkiewicz M, Gruca P, Papp M, Zorn SH, Doller D, K?eczek N, Noworyta-Soko?owska K, Go?embiowska K, Pilc A. The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT1A receptor signaling: mechanistic studies. Psychopharmacology. 232: 259-73. PMID 25012236 DOI: 10.1007/S00213-014-3657-4 |
0.411 |
|
| 2015 |
Chilmonczyk Z, Bojarski AJ, Pilc A, Sylte I. Functional selectivity and antidepressant activity of serotonin 1A receptor ligands International Journal of Molecular Sciences. 16: 18474-18506. DOI: 10.3390/Ijms160818474 |
0.419 |
|
| 2015 |
Rzezniczek S, Podkowa K, Marciniak M, Acher F, Pilc A, Palucha-Poniewiera A. P.2.a.008 Pro-depressive-like effects of mGlu4 selective agonist LSP4–2022 in mice European Neuropsychopharmacology. 25. DOI: 10.1016/S0924-977X(15)30492-2 |
0.338 |
|
| 2015 |
Podkowa K, Pałucha-Poniewiera A, Poli S, Pilc A. Potential anxiolytic- and antidepressant-like activity of Dipraglurant (ADX48621), the novel negative allosteric modulator (NAM) of the metabotropic glutamate 5 (mGlu5) receptor Pharmacological Reports. 67: 34-35. DOI: 10.1016/J.Pharep.2015.06.105 |
0.451 |
|
| 2015 |
Wierońska JM, Woźniak M, Acher F, Pilc A. The mechanism of antipsychotic-like action of the mGlu receptor activators: Focus on GABAergic signaling Pharmacological Reports. 67: 7. DOI: 10.1016/J.Pharep.2015.06.024 |
0.389 |
|
| 2014 |
Marciniak M, Chruscicka B, Lech T, Burnat G, Pilc A. Expression of group III metabotropic glutamate receptors in the reproductive system of male mice. Reproduction, Fertility, and Development. PMID 25066043 DOI: 10.1071/Rd14132 |
0.402 |
|
| 2014 |
Zaniewska M, Przegaliński E, Filip M, Pilc A, Doller D. Inhibitory actions of mGlu4 receptor ligands on cocaine-, but not nicotine-, induced sensitizing and conditioning locomotor responses in rats. Pharmacological Reports : Pr. 66: 205-11. PMID 24911071 DOI: 10.1016/J.Pharep.2013.12.001 |
0.357 |
|
| 2014 |
Nowak G, Pomierny-Chamioło L, Siwek A, Niedzielska E, Pomierny B, Pałucha-Poniewiera A, Pilc A. Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors. Neuropharmacology. 84: 46-51. PMID 24796254 DOI: 10.1016/J.Neuropharm.2014.04.016 |
0.482 |
|
| 2014 |
Ossowska K, Wardas J, Berghauzen-Maciejewska K, GÅ‚owacka U, Kuter K, Pilc A, Zorn SH, Doller D. Lu AF21934, a positive allosteric modulator of mGlu4 receptors, reduces the harmaline-induced hyperactivity but not tremor in rats. Neuropharmacology. 83: 28-35. PMID 24726309 DOI: 10.1016/J.Neuropharm.2014.03.018 |
0.399 |
|
| 2014 |
Jantas D, Greda A, Golda S, Korostynski M, Grygier B, Roman A, Pilc A, Lason W. Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP(+)-induced cell death in human neuroblastoma SH-SY5Y cells: the impact of cell differentiation state. Neuropharmacology. 83: 36-53. PMID 24713472 DOI: 10.1016/J.Neuropharm.2014.03.019 |
0.355 |
|
| 2014 |
Pałucha-Poniewiera A, Szewczyk B, Pilc A. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats. Neuropharmacology. 82: 59-68. PMID 24631968 DOI: 10.1016/J.Neuropharm.2014.03.001 |
0.47 |
|
| 2014 |
Pałucha-Poniewiera A, Brański P, Wierońska JM, Stachowicz K, Sławińska A, Pilc A. The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent. Psychopharmacology. 231: 97-107. PMID 23958941 DOI: 10.1007/S00213-013-3206-6 |
0.45 |
|
| 2013 |
Pałucha-Poniewiera A, Wierońska JM, Brański P, Burnat G, Chruścicka B, Pilc A. Is the mGlu5 receptor a possible target for new antidepressant drugs? Pharmacological Reports : Pr. 65: 1506-11. PMID 24552998 DOI: 10.1016/S1734-1140(13)71511-1 |
0.447 |
|
| 2013 |
Wolak M, Siwek A, Szewczyk B, Poleszak E, Pilc A, Popik P, Nowak G. Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test. Pharmacological Reports : Pr. 65: 991-7. PMID 24145093 DOI: 10.1016/S1734-1140(13)71080-6 |
0.368 |
|
| 2013 |
Sowa-Kućma M, Szewczyk B, Sadlik K, Piekoszewski W, Trela F, Opoka W, Poleszak E, Pilc A, Nowak G. Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims. Journal of Affective Disorders. 151: 924-31. PMID 24055117 DOI: 10.1016/J.Jad.2013.08.009 |
0.307 |
|
| 2013 |
Sławińska A, Wierońska JM, Stachowicz K, Marciniak M, Lasoń-Tyburkiewicz M, Gruca P, Papp M, Kusek M, Tokarski K, Doller D, Pilc A. The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents. British Journal of Pharmacology. 169: 1824-39. PMID 23714045 DOI: 10.1111/Bph.12254 |
0.408 |
|
| 2013 |
WieroÅ„ska JM, Acher FC, SÅ‚awiÅ„ska A, Gruca P, LasoÅ„-Tyburkiewicz M, Papp M, Pilc A. The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HTâ‚A signalling. Psychopharmacology. 227: 711-25. PMID 23474845 DOI: 10.1007/S00213-013-3005-0 |
0.449 |
|
| 2013 |
Pilc A, Wierońska JM, Skolnick P. Glutamate-based antidepressants: preclinical psychopharmacology. Biological Psychiatry. 73: 1125-32. PMID 23453290 DOI: 10.1016/J.Biopsych.2013.01.021 |
0.395 |
|
| 2013 |
Pałucha-Poniewiera A, Pilc A. A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats. Behavioural Brain Research. 238: 109-12. PMID 23085340 DOI: 10.1016/J.Bbr.2012.10.004 |
0.491 |
|
| 2013 |
Chaki S, Ago Y, Palucha-Paniewiera A, Matrisciano F, Pilc A. mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants. Neuropharmacology. 66: 40-52. PMID 22640631 DOI: 10.1016/J.Neuropharm.2012.05.022 |
0.45 |
|
| 2013 |
Chruścicka B, Burnat G, Brański P, Pilc A. Expression of metabotropic glutamate receptors in mammalian cells as a method for identification of new chemical compounds with drug-like activity Pharmacological Reports. 65: 38. DOI: 10.1016/S1734-1140(13)71313-6 |
0.389 |
|
| 2013 |
Wierońska JM, Sławińska A, Stachowicz K, Pilc A. Metabotropic glutamate receptors PAMs as a novel, potential antipsychotic drugs Pharmacological Reports. 65: 23. DOI: 10.1016/S1734-1140(13)71291-X |
0.41 |
|
| 2013 |
Pilc A, Pałucha-Poniewiera A, Brański P, Stachowicz K, Sławińska A, Pomierny-Chamioło L, Nowak G. On the mechanism of antidepressant-like activity of mGlu5 allosteric modulators Pharmacological Reports. 65: 22-23. DOI: 10.1016/S1734-1140(13)71290-8 |
0.321 |
|
| 2013 |
Chruscicka B, Branski P, Burnat G, Pilc A. P.1.009 Cell synchronisation as a tool to optimise expression of metabotropic glutamate receptors in inducible mammalian expression system European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70011-7 |
0.357 |
|
| 2012 |
Pałucha-Poniewiera A, Pilc A. Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 39: 102-6. PMID 22651960 DOI: 10.1016/J.Pnpbp.2012.05.015 |
0.473 |
|
| 2012 |
Wierońska JM, Stachowicz K, Acher F, Lech T, Pilc A. Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia. Psychopharmacology. 220: 481-94. PMID 21952670 DOI: 10.1007/S00213-011-2502-2 |
0.416 |
|
| 2012 |
Wierońska JM, Pilc A, Doller D, Gruca P, Łasoń-Tyburkiewicz M, Papp M. mGlu4-dependent reversal of the MK-801-induced cognitive impartment involves 5-HT1A receptors Pharmacological Reports. 64: 486. DOI: 10.1016/S1734-1140(12)70818-6 |
0.364 |
|
| 2012 |
Chruścicka B, Brański P, Burnat G, Chorobik P, Pilc A. Cell synchronization as a tool to optimize protein expression level of mGlu receptors in applying the inducible expression system Pharmacological Reports. 64: 472. DOI: 10.1016/S1734-1140(12)70802-2 |
0.313 |
|
| 2012 |
Zaniewska M, Przegalinski E, Filip M, Pilc A, Uberti MA, Bacolod MD, Doller D. S.24.04 Inhibitory actions of mGlu4 receptor ligands on cocaine- but not nicotine-induced locomotor responses in rats European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70191-8 |
0.355 |
|
| 2012 |
Slawinska A, Wieronska JM, Stachowicz K, Palucha-Poniewiera A, Pilc A, Uberti MA, Bacolod MD, Doller D. P.2.015 An anxiolytic but not antidepressant-like activity of a novel positive modulator of mGlu4 receptor Lu AF21394 European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70047-0 |
0.345 |
|
| 2011 |
Partyka A, Jastrzębska-Więsek M, Szewczyk B, Stachowicz K, Sławińska A, Poleszak E, Doboszewska U, Pilc A, Nowak G. Anxiolytic-like activity of zinc in rodent tests. Pharmacological Reports : Pr. 63: 1050-5. PMID 22001993 DOI: 10.1016/S1734-1140(11)70621-1 |
0.349 |
|
| 2011 |
Stachowicz K, Wierońska J, Domin H, Chaki S, Pilc A. Anxiolytic-like activity of MGS0039, a selective group II mGlu receptor antagonist, is serotonin- and GABA-dependent. Pharmacological Reports : Pr. 63: 880-7. PMID 22001975 DOI: 10.1016/S1734-1140(11)70603-X |
0.424 |
|
| 2011 |
Wierońska JM, Kusek M, Tokarski K, Wabno J, Froestl W, Pilc A. The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice. British Journal of Pharmacology. 163: 1034-47. PMID 21371011 DOI: 10.1111/J.1476-5381.2011.01301.X |
0.464 |
|
| 2011 |
Sowa-Kućma M, Kowalska M, Szlósarczyk M, Gołembiowska K, Opoka W, Baś B, Pilc A, Nowak G. Chronic treatment with zinc and antidepressants induces enhancement of presynaptic/extracellular zinc concentration in the rat prefrontal cortex. Amino Acids. 40: 249-58. PMID 20532950 DOI: 10.1007/S00726-010-0641-0 |
0.348 |
|
| 2011 |
Wierońska JM, Stachowicz K, Sławińska A, Pilc A. On the mechanisms of anxiolytic-like effects of mGlu2/3 receptor agonist LY 379268 and positive modulator LY487379 in stress-induced hyperthermia model in mice Pharmacological Reports. 63: 581. DOI: 10.1016/S1734-1140(11)70553-9 |
0.39 |
|
| 2011 |
Stachowicz K, Wierońska JM, Szewczyk B, Sowa-Kućma M, Sławińska A, Pilc A. Anxiolytic-like action of LY487379 after central administration in rats Pharmacological Reports. 63: 580. DOI: 10.1016/S1734-1140(11)70552-7 |
0.306 |
|
| 2011 |
Burnat G, Brański P, Chorobik P, Chruścicka B, Pilc A. Validation of HEK-293 cell line as a molecular tool for pharmacological study of mGluR7 receptor Pharmacological Reports. 63: 577-578. DOI: 10.1016/S1734-1140(11)70548-5 |
0.348 |
|
| 2011 |
Brański P, Staroń J, Bugno R, Wierońska J, Bojarski A, Pałucha-Poniewiera A, Pilc A, Burnat G. Synthesis and characterization of novel metabotropic glutamate receptor 2/3 (mGluR2/3) positive allosteric modulator (PAM) Pharmacological Reports. 63: 577-577. DOI: 10.1016/S1734-1140(11)70547-3 |
0.405 |
|
| 2010 |
Pomierny-Chamioło L, Poleszak E, Pilc A, Nowak G. NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice. Pharmacological Reports : Pr. 62: 1186-90. PMID 21273676 DOI: 10.1016/S1734-1140(10)70381-9 |
0.484 |
|
| 2010 |
Wierońska JM, Stachowicz K, Pałucha-Poniewiera A, Acher F, Brański P, Pilc A. Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems. Neuropharmacology. 59: 627-34. PMID 20713068 DOI: 10.1016/j.neuropharm.2010.08.008 |
0.346 |
|
| 2010 |
Pałucha-Poniewiera A, Wierońska JM, Brański P, Stachowicz K, Chaki S, Pilc A. On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039. Psychopharmacology. 212: 523-35. PMID 20703449 DOI: 10.1007/S00213-010-1978-5 |
0.381 |
|
| 2010 |
Pałucha-Poniewiera A, Brański P, Lenda T, Pilc A. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent. The Journal of Pharmacology and Experimental Therapeutics. 334: 1066-74. PMID 20562216 DOI: 10.1124/Jpet.110.169730 |
0.482 |
|
| 2010 |
Wierońska JM, Brański P, Siwek A, Dybala M, Nowak G, Pilc A. GABAergic dysfunction in mGlu7 receptor-deficient mice as reflected by decreased levels of glutamic acid decarboxylase 65 and 67kDa and increased reelin proteins in the hippocampus. Brain Research. 1334: 12-24. PMID 20353761 DOI: 10.1016/J.Brainres.2010.03.078 |
0.386 |
|
| 2010 |
Szewczyk B, Poleszak E, Sowa-Kućma M, Wróbel A, Słotwiński S, Listos J, Wlaź P, Cichy A, Siwek A, Dybała M, Gołembiowska K, Pilc A, Nowak G. The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test. Amino Acids. 39: 205-17. PMID 19956994 DOI: 10.1007/S00726-009-0412-Y |
0.474 |
|
| 2010 |
Wierońska JM, Brański P, Pałucha-Poniewiera A, Pilc A. Antidepressant-like activity of metabotropic glutamate receptors Pharmacological Reports. 62: 23-24. DOI: 10.1016/S1734-1140(10)71114-2 |
0.444 |
|
| 2010 |
Nowak G, Sowa-Kućma M, Szewczyk B, Poleszak E, Pilc A. Zinc and magnesium interaction with glutamate system in depression Pharmacological Reports. 62: 23. DOI: 10.1016/S1734-1140(10)71113-0 |
0.307 |
|
| 2010 |
Wieronska JM, Branski P, Lech T, Marciniak M, Pilc A. P.2.h.004 Antidepressant and antipsychotic-like effects of GABA-B receptor ligands in mGlu7 deficient mice European Neuropsychopharmacology. 20. DOI: 10.1016/S0924-977X(10)70620-9 |
0.358 |
|
| 2010 |
Pilc A, Palucha-Poniewiera A, Wieronska J, Stachowicz K, Branski P, Siwek A, Dybala M, Nowak G. S.28.04 The antidepressant potential of mGluR5 and GABA-B receptor antagonists in rodent models of depression European Neuropsychopharmacology. 20. DOI: 10.1016/S0924-977X(10)70240-6 |
0.386 |
|
| 2009 |
Cichy A, Sowa-Kućma M, Legutko B, Pomierny-Chamioło L, Siwek A, Piotrowska A, Szewczyk B, Poleszak E, Pilc A, Nowak G. Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors. Pharmacological Reports : Pr. 61: 1184-91. PMID 20081255 DOI: 10.1016/S1734-1140(09)70182-3 |
0.437 |
|
| 2009 |
Pałucha-Poniewiera A, Novák K, Pilc A. Group III mGlu receptor agonist, ACPT-I, attenuates morphine-withdrawal symptoms after peripheral administration in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 1454-7. PMID 19660510 DOI: 10.1016/J.Pnpbp.2009.07.029 |
0.429 |
|
| 2009 |
Stachowicz K, Kłodzińska A, Palucha-Poniewiera A, Schann S, Neuville P, Pilc A. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems. Neuropharmacology. 57: 227-34. PMID 19539634 DOI: 10.1016/J.Neuropharm.2009.06.005 |
0.463 |
|
| 2009 |
Wierońska JM, Pilc A. Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs. Neurochemistry International. 55: 85-97. PMID 19428811 DOI: 10.1016/J.Neuint.2009.02.019 |
0.435 |
|
| 2009 |
Siwek M, Dudek D, Paul IA, Sowa-Kućma M, Zieba A, Popik P, Pilc A, Nowak G. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. Journal of Affective Disorders. 118: 187-95. PMID 19278731 DOI: 10.1016/J.Jad.2009.02.014 |
0.345 |
|
| 2009 |
Szewczyk B, Poleszak E, Wlaź P, Wróbel A, Blicharska E, Cichy A, Dybała M, Siwek A, Pomierny-Chamioło L, Piotrowska A, Brański P, Pilc A, Nowak G. The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33: 323-9. PMID 19150479 DOI: 10.1016/J.Pnpbp.2008.12.011 |
0.397 |
|
| 2009 |
Wierońska JM, Pilc A. The role of GABAergic transmission in the behavioral effects of mGlu7 receptor positive modulator, AMN082 Pharmacological Reports. 61: 379-379. DOI: 10.1016/S1734-1140(09)70079-9 |
0.374 |
|
| 2009 |
Stachowicz K, Domin H, Pilc A. P.4.01 Effects of group II metabotropic glutamate receptor antagonist, MGS0039 in rodent tests of anxiety-like behaviour European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70170-1 |
0.424 |
|
| 2009 |
Stachowicz K, Nikiforuk A, Wieronska J, Chojnacka-Wójcik E, Pilc A. P.2.25 Anxiolytic-like effects of LY487379 an allosteric modulator of mGlu2 receptors in rats European Neuropsychopharmacology. 19: S54-S55. DOI: 10.1016/S0924-977X(09)70063-X |
0.424 |
|
| 2008 |
Poleszak E, Szewczyk B, Wlaź A, Fidecka S, Wlaź P, Pilc A, Nowak G. D-serine, a selective glycine/N-methyl-D-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice. Pharmacological Reports : Pr. 60: 996-1000. PMID 19211995 |
0.329 |
|
| 2008 |
Dybała M, Siwek A, Poleszak E, Pilc A, Nowak G. Lack of NMDA-AMPA interaction in antidepressant-like effect of CGP 37849, an antagonist of NMDA receptor, in the forced swim test. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 1519-20. PMID 18839056 DOI: 10.1007/S00702-008-0128-2 |
0.437 |
|
| 2008 |
Pedersen ME, Szewczyk B, Stachowicz K, Wieronska J, Andersen J, Stafford GI, van Staden J, Pilc A, Jäger AK. Effects of South African traditional medicine in animal models for depression. Journal of Ethnopharmacology. 119: 542-8. PMID 18809486 DOI: 10.1016/J.Jep.2008.08.030 |
0.315 |
|
| 2008 |
Sowa-Kućma M, Legutko B, Szewczyk B, Novak K, Znojek P, Poleszak E, Papp M, Pilc A, Nowak G. Antidepressant-like activity of zinc: further behavioral and molecular evidence. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 1621-8. PMID 18766297 DOI: 10.1007/S00702-008-0115-7 |
0.337 |
|
| 2008 |
Pałucha-Poniewiera A, Kłodzińska A, Stachowicz K, Tokarski K, Hess G, Schann S, Frauli M, Neuville P, Pilc A. Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents. Neuropharmacology. 55: 517-24. PMID 18619473 DOI: 10.1016/J.Neuropharm.2008.06.033 |
0.463 |
|
| 2008 |
Brański P, Palucha A, Szewczyk B, Wierońska JM, Pilc A, Nowak G. Antidepressant-like activity of 8-Br-cAMP, a PKA activator, in the forced swim test. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 829-30. PMID 18239846 DOI: 10.1007/S00702-008-0023-X |
0.317 |
|
| 2008 |
Pilc A, Chaki S, Nowak G, Witkin JM. Mood disorders: regulation by metabotropic glutamate receptors. Biochemical Pharmacology. 75: 997-1006. PMID 18164691 DOI: 10.1016/J.Bcp.2007.09.021 |
0.461 |
|
| 2007 |
Poleszak E, Wlaź P, Wróbel A, Dybała M, Sowa M, Fidecka S, Pilc A, Nowak G. Activation of the NMDA/glutamate receptor complex antagonizes the NMDA antagonist-induced antidepressant-like effects in the forced swim test. Pharmacological Reports : Pr. 59: 595-600. PMID 18048961 |
0.311 |
|
| 2007 |
Wierońska JM, Kłak K, Pałucha A, Brański P, Pilc A. Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex. Brain Research. 1184: 88-95. PMID 17976546 DOI: 10.1016/J.Brainres.2007.10.006 |
0.479 |
|
| 2007 |
Stachowicz K, Gołembiowska K, Sowa M, Nowak G, Chojnacka-Wójcik E, Pilc A. Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent. Neuropharmacology. 53: 741-8. PMID 17870136 DOI: 10.1016/J.Neuropharm.2007.08.002 |
0.472 |
|
| 2007 |
Poleszak E, Wlaź P, Kedzierska E, Nieoczym D, Wróbel A, Fidecka S, Pilc A, Nowak G. NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice. Pharmacology, Biochemistry, and Behavior. 88: 158-64. PMID 17825400 DOI: 10.1016/J.Pbb.2007.07.018 |
0.394 |
|
| 2007 |
Palucha A, Klak K, Branski P, van der Putten H, Flor PJ, Pilc A. Activation of the mGlu7 receptor elicits antidepressant-like effects in mice. Psychopharmacology. 194: 555-62. PMID 17622518 DOI: 10.1007/S00213-007-0856-2 |
0.455 |
|
| 2007 |
Palucha A, Pilc A. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacology & Therapeutics. 115: 116-47. PMID 17582504 DOI: 10.1016/J.Pharmthera.2007.04.007 |
0.481 |
|
| 2007 |
Pilc A, Ossowska K. Metabotropic glutamate receptors. Amino Acids. 32: 165-7. PMID 17245617 DOI: 10.1007/S00726-006-0315-0 |
0.441 |
|
| 2007 |
Konieczny J, Wardas J, Kuter K, Pilc A, Ossowska K. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats. Neuroscience. 145: 611-20. PMID 17224239 DOI: 10.1016/J.Neuroscience.2006.12.006 |
0.37 |
|
| 2007 |
Stachowicz K, Chojnacka-Wójcik E, Kłak K, Pilc A. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent. Neuropharmacology. 52: 306-12. PMID 17020774 DOI: 10.1016/J.Neuropharm.2006.08.002 |
0.481 |
|
| 2007 |
Kłak K, Pałucha A, Brański P, Sowa M, Pilc A. Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats. Amino Acids. 32: 169-72. PMID 16868652 DOI: 10.1007/S00726-006-0316-Z |
0.51 |
|
| 2007 |
Ossowska K, Konieczny J, Wardas J, Pietraszek M, Kuter K, Wolfarth S, Pilc A. An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats. Amino Acids. 32: 179-88. PMID 16699817 DOI: 10.1007/S00726-006-0317-Y |
0.39 |
|
| 2006 |
Nowak G, Partyka A, Pałucha A, Szewczyk B, Wierońska JM, Dybała M, Metz M, Librowski T, Froestl W, Papp M, Pilc A. Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents. British Journal of Pharmacology. 149: 581-90. PMID 16921399 DOI: 10.1038/Sj.Bjp.0706845 |
0.456 |
|
| 2006 |
Legutko B, Szewczyk B, Pomierny-Chamioło L, Nowak G, Pilc A. Effect of MPEP treatment on brain-derived neurotrophic factor gene expression. Pharmacological Reports : Pr. 58: 427-30. PMID 16845218 |
0.316 |
|
| 2006 |
Stachowicz K, Chojnacka-Wójcik E, Klak K, Pilc A. Anxiolytic-like effects of group III mGluR positive modulator PHCCC and agonist ACPT-I injected to the rat hippocampus European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)80102-1 |
0.453 |
|
| 2006 |
Zieba B, Uchacz T, Domin H, Branski P, Smialowska M, Pilc A. The anxiolytic effect of CRF in rat brain frontal cortex is prevented by CRF1&2 receptor antagonists European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)80065-9 |
0.389 |
|
| 2005 |
Pilc A, Nowak G. GABAergic hypotheses of anxiety and depression: focus on GABA-B receptors. Drugs of Today (Barcelona, Spain : 1998). 41: 755-66. PMID 16395415 DOI: 10.1358/Dot.2005.41.11.904728 |
0.456 |
|
| 2005 |
Stachowicz K, Kłak K, Pilc A, Chojnacka-Wójcik E. Lack of the antianxiety-like effect of (S)-3,4-DCPG, an mGlu8 receptor agonist, after central administration in rats. Pharmacological Reports : Pr. 57: 856-60. PMID 16382208 |
0.337 |
|
| 2005 |
Pałucha A, Brański P, Szewczyk B, Wierońska JM, Kłak K, Pilc A. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist. Pharmacology, Biochemistry, and Behavior. 81: 901-6. PMID 16040106 DOI: 10.1016/J.Pbb.2005.06.015 |
0.444 |
|
| 2005 |
Palucha A, Pilc A. The involvement of glutamate in the pathophysiology of depression. Drug News & Perspectives. 18: 262-8. PMID 16034483 DOI: 10.1358/Dnp.2005.18.4.908661 |
0.446 |
|
| 2005 |
Poleszak E, Wlaź P, Szewczyk B, Kedzierska E, Wyska E, Librowski T, Szymura-Oleksiak J, Fidecka S, Pilc A, Nowak G. Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice. Pharmacology, Biochemistry, and Behavior. 81: 524-9. PMID 15936065 DOI: 10.1016/J.Pbb.2005.03.017 |
0.332 |
|
| 2005 |
Ossowska K, Konieczny J, Wolfarth S, Pilc A. MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats. Neuropharmacology. 49: 447-55. PMID 15919101 DOI: 10.1016/J.Neuropharm.2005.04.002 |
0.379 |
|
| 2005 |
Ossowska K, Konieczny J, Wardas J, Pietraszek M, Wolfarth S, Pilc A. B12 Metabotropic Glutamate Receptors As Potential Targets Of Antiparkinsonian Therapy Behavioural Pharmacology. 16. DOI: 10.1097/00008877-200509001-00217 |
0.351 |
|
| 2004 |
Stachowicz K, Kłak K, Kłodzińska A, Chojnacka-Wojcik E, Pilc A. Anxiolytic-like effects of PHCCC, an allosteric modulator of mGlu4 receptors, in rats. European Journal of Pharmacology. 498: 153-6. PMID 15363989 DOI: 10.1016/J.Ejphar.2004.07.001 |
0.443 |
|
| 2004 |
Klodzinska A, Tatarczyńska E, Chojnacka-Wójcik E, Nowak G, Cosford ND, Pilc A. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling. Neuropharmacology. 47: 342-50. PMID 15275823 DOI: 10.1016/J.Neuropharm.2004.04.013 |
0.471 |
|
| 2004 |
Poleszak E, Szewczyk B, Kedzierska E, Wlaź P, Pilc A, Nowak G. Antidepressant- and anxiolytic-like activity of magnesium in mice. Pharmacology, Biochemistry, and Behavior. 78: 7-12. PMID 15159129 DOI: 10.1016/J.Pbb.2004.01.006 |
0.371 |
|
| 2004 |
Pałucha A, Tatarczyńska E, Brański P, Szewczyk B, Wierońska JM, Kłak K, Chojnacka-Wójcik E, Nowak G, Pilc A. Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats. Neuropharmacology. 46: 151-9. PMID 14680755 DOI: 10.1016/J.Neuropharm.2003.09.006 |
0.465 |
|
| 2004 |
Wierońska JM, Smiałowska M, Brański P, Gasparini F, Kłodzińska A, Szewczyk B, Pałucha A, Chojnacka-Wójcik E, Pilc A. In the amygdala anxiolytic action of mGlu5 receptors antagonist MPEP involves neuropeptide Y but not GABAA signaling. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 514-21. PMID 14666119 DOI: 10.1038/Sj.Npp.1300322 |
0.4 |
|
| 2004 |
Wieronska J, Śmiałowska M, Brański P, Kłodzińska A, Szewczyk B, Pałucha A, Chojnacka-Wojcik E, Pilc A. P.2.12 Interaction between metabotropic glutamate 5 receptors and NPY in the amygdala as a novel mechanism of anxiolysis European Neuropsychopharmacology. 14. DOI: 10.1016/S0924-977X(04)90035-1 |
0.385 |
|
| 2004 |
Klodzinska A, Tatarczyńska E, Chojnacka-Wójcik E, Nowak G, Cosford NDP, Pilc A. Corrigendum to “Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor antagonist does not involve GABAA signaling” [Neuropharmacology 47 (2004) 342–350] Neuropharmacology. 47: 1115. DOI: 10.1016/J.Neuropharm.2004.08.006 |
0.438 |
|
| 2003 |
Nowak G, Szewczyk B, Wieronska JM, Branski P, Palucha A, Pilc A, Sadlik K, Piekoszewski W. Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Research Bulletin. 61: 159-64. PMID 12832002 DOI: 10.1016/S0361-9230(03)00104-7 |
0.351 |
|
| 2003 |
Kozela E, Pilc A, Popik P. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology. 165: 245-51. PMID 12442203 DOI: 10.1007/S00213-002-1287-8 |
0.399 |
|
| 2002 |
Pałucha A, Pilc A. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants. Polish Journal of Pharmacology. 54: 581-6. PMID 12866712 |
0.322 |
|
| 2002 |
Wieronska JM, Szewczyk B, Branski P, Palucha A, Pilc A. Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats. Amino Acids. 23: 213-6. PMID 12373540 DOI: 10.1007/S00726-001-0131-5 |
0.424 |
|
| 2002 |
Kuhn R, Pagano A, Stoehr N, Vranesic I, Flor PJ, Lingenhöhl K, Spooren W, Gentsch C, Vassout A, Pilc A, Gasparini F. In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article. Amino Acids. 23: 207-11. PMID 12373539 DOI: 10.1007/S00726-001-0130-6 |
0.441 |
|
| 2002 |
Ossowska K, Konieczny J, Wardas J, Gołembiowska K, Wolfarth S, Pilc A. The role of striatal metabotropic glutamate receptors in Parkinson's disease. Amino Acids. 23: 193-8. PMID 12373537 DOI: 10.1007/S00726-001-0128-0 |
0.385 |
|
| 2002 |
Ossowska K, Konieczny J, Pilc A, Wolfarth S. The striatum as a target for anti-rigor effects of an antagonist of mGluR1, but not an agonist of group II metabotropic glutamate receptors. Brain Research. 950: 88-94. PMID 12231232 DOI: 10.1016/S0006-8993(02)03005-6 |
0.374 |
|
| 2002 |
Pilc A, Kłodzińska A, Brański P, Nowak G, Pałucha A, Szewczyk B, Tatarczyńska E, Chojnacka-Wójcik E, Wierońska JM. Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats. Neuropharmacology. 43: 181-7. PMID 12213272 DOI: 10.1016/S0028-3908(02)00082-5 |
0.496 |
|
| 2002 |
Smiałowska M, Szewczyk B, Brański P, Wierońska JM, Pałucha A, Bajkowska M, Pilc A. Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus. Neuropharmacology. 42: 1016-23. PMID 12128002 DOI: 10.1016/S0028-3908(02)00062-X |
0.376 |
|
| 2002 |
KÅ‚odzinska A, Bijak M, Tokarski K, Pilc A. Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice. Pharmacology, Biochemistry, and Behavior. 73: 327-32. PMID 12117586 DOI: 10.1016/S0091-3057(02)00845-6 |
0.459 |
|
| 2002 |
Palucha A, Branski P, Szewczyk B, Wieronska JM, Tokarski K, Pilc A. Potential anti-addictive effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist European Neuropsychopharmacology. 12: 390. DOI: 10.1016/S0924-977X(02)80646-0 |
0.412 |
|
| 2001 |
Tatarczyńska E, Kłodzińska A, Kroczka B, Chojnacka-Wójcik E, Pilc A. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration. Psychopharmacology. 158: 94-9. PMID 11685389 DOI: 10.1007/S002130100798 |
0.443 |
|
| 2001 |
Ossowska K, Konieczny J, Wolfarth S, Wierońska J, Pilc A. Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats. Neuropharmacology. 41: 413-20. PMID 11543761 DOI: 10.1016/S0028-3908(01)00083-1 |
0.392 |
|
| 2001 |
Kroczka B, Branski P, Palucha A, Pilc A, Nowak G. Antidepressant-like properties of zinc in rodent forced swim test. Brain Research Bulletin. 55: 297-300. PMID 11470330 DOI: 10.1016/S0361-9230(01)00473-7 |
0.37 |
|
| 2001 |
Lorenc-Koci E, Wardas J, Wolfarth S, Pilc A. (S)-4C3HPG, a mixed group I mGlu receptor antagonist and a group II agonist, administered intrastriatally, counteracts parkinsonian-like muscle rigidity in rats. Brain Research. 903: 177-84. PMID 11382401 DOI: 10.1016/S0006-8993(01)02438-6 |
0.366 |
|
| 2001 |
Tatarczyńska E, Klodzińska A, Chojnacka-Wójcik E, Palucha A, Gasparini F, Kuhn R, Pilc A. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. British Journal of Pharmacology. 132: 1423-30. PMID 11264235 DOI: 10.1038/Sj.Bjp.0703923 |
0.452 |
|
| 2001 |
Klodzinska A, Chojnacka-Wójcik E, Pilc A. Anxiolytic-like effects of CGP 36742 an antagonist of GABAB receptors in animal models European Neuropsychopharmacology. 11. DOI: 10.1016/S0924-977X(01)80430-2 |
0.428 |
|
| 2001 |
Palucha A, Branski P, Kroczka B, Wieronska JM, Pilc A. Potential antidepressant-like effects of MPEP, a potent, selective and systemically active mGluR5 receptor antagonist European Neuropsychopharmacology. 11. DOI: 10.1016/S0924-977X(01)80233-9 |
0.437 |
|
| 2000 |
Wolfarth S, Konieczny J, Lorenc-Koci E, Ossowska K, Pilc A. The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity. Amino Acids. 19: 95-101. PMID 11026478 DOI: 10.1007/S007260070038 |
0.399 |
|
| 2000 |
Ossowska K, Pietraszek M, Wardas J, Nowak G, Zajaczkowski W, Wolfarth S, Pilc A. The role of glutamate receptors in antipsychotic drug action. Amino Acids. 19: 87-94. PMID 11026477 DOI: 10.1007/S007260070037 |
0.433 |
|
| 2000 |
Pilc A, Chojnacka-Wójcik E, Tatarczyńska E, Borycz J, Kroczka B. Stimulation of group II metabotropic glutamate receptors or inhibition of group I ones exerts anxiolytic-like effects in rats. Amino Acids. 19: 81-6. PMID 11026476 DOI: 10.1007/S007260070036 |
0.456 |
|
| 2000 |
Popik P, Kozela E, Pilc A. Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice. British Journal of Pharmacology. 130: 1425-31. PMID 10903986 DOI: 10.1038/Sj.Bjp.0703438 |
0.412 |
|
| 2000 |
Kłodzińska A, Bijak M, Chojnacka-Wójcik E, Kroczka B, Swiader M, Czuczwar SJ, Pilc A. Roles of group II metabotropic glutamate receptors in modulation of seizure activity. Naunyn-Schmiedeberg's Archives of Pharmacology. 361: 283-8. PMID 10731041 DOI: 10.1007/S002109900197 |
0.422 |
|
| 2000 |
Frankiewicz T, Pilc A, Parsons CG. Differential effects of NMDA-receptor antagonists on long-term potentiation and hypoxic/hypoglycaemic excitotoxicity in hippocampal slices. Neuropharmacology. 39: 631-42. PMID 10728884 DOI: 10.1016/S0028-3908(99)00168-9 |
0.337 |
|
| 1999 |
Kłodzińska A, Chojnacka-Wójcik E, Pałucha A, Brański P, Popik P, Pilc A. Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models. Neuropharmacology. 38: 1831-9. PMID 10608278 DOI: 10.1016/S0028-3908(99)00066-0 |
0.489 |
|
| 1999 |
Pilc A, Branski P, Palucha A, Aronowski J. The effect of prolonged imipramine and electroconvulsive shock treatment on calcium/calmodulin-dependent protein kinase II in the hippocampus of rat brain. Neuropharmacology. 38: 597-603. PMID 10221763 DOI: 10.1016/S0028-3908(98)00211-1 |
0.32 |
|
| 1998 |
Konieczny J, Ossowska K, Wolfarth S, Pilc A. LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 358: 500-2. PMID 9826074 DOI: 10.1007/Pl00005284 |
0.407 |
|
| 1998 |
Pilc A, Brański P, Pałucha A, Tokarski K, Bijak M. Antidepressant treatment influences group I of glutamate metabotropic receptors in slices from hippocampal CA1 region. European Journal of Pharmacology. 349: 83-7. PMID 9669500 DOI: 10.1016/S0014-2999(98)00169-1 |
0.387 |
|
| 1997 |
Chojnacka-Wójcik E, Tatarczyńska E, Pilc A. The anxiolytic-like effect of metabotropic glutamate receptor antagonists after intrahippocampal injection in rats. European Journal of Pharmacology. 319: 153-6. PMID 9042585 DOI: 10.1016/S0014-2999(96)00941-7 |
0.438 |
|
| 1997 |
Pilc A, Bijak M, Tokarski K, Legutko B. Antidepressant treatment influences metabotropic receptors for excitatory amino acids in rat brain Biological Psychiatry. 42. DOI: 10.1016/S0006-3223(97)88110-3 |
0.386 |
|
| 1996 |
Pilc A, Legutko B, Czyrak A. The enhancement and the inhibition of noradrenaline-induced cyclic AMP accumulation in rat brain by stimulation of metabotropic glutamate receptors. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 20: 673-90. PMID 8843491 DOI: 10.1016/0278-5846(96)00040-1 |
0.343 |
|
| 1996 |
Pilc A, Popik P, Tatarczyńska E, Wójcik E. The antagonists of metabotropic glutamate receptors produce anxiolytic-like effects and attenuate morphine abstinence symptoms in animals Neuropharmacology. 35: A23. DOI: 10.1016/0028-3908(96)84736-8 |
0.423 |
|
| 1995 |
Pilc A, Legutko B. The influence of prolonged antidepressant treatment on the changes in cyclic AMP accumulation induced by excitatory amino acids in rat cerebral cortical slices. Neuroreport. 7: 85-88. DOI: 10.1097/00001756-199512000-00020 |
0.354 |
|
| 1992 |
Pilc A, Nowak G, Zak J. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible receptor inactivator, as a tool for measurement of alpha 2-adrenoceptor occupancy in vivo. European Journal of Pharmacology. 212: 109-11. PMID 1348228 DOI: 10.1016/0014-2999(92)90081-E |
0.314 |
|
| 1988 |
Pilc A, Nalepa I, Vetulani J. Reserpinization enhances electroconvulsive treatment effects on cortical alpha 1-adrenoceptors. European Journal of Pharmacology. 157: 231-4. PMID 2852115 DOI: 10.1016/0014-2999(88)90388-3 |
0.374 |
|
| 1984 |
Pilc A, Lloyd KG. Chronic antidepressants and GABA "B" receptors: a GABA hypothesis of antidepressant drug action. Life Sciences. 35: 2149-54. PMID 6092815 DOI: 10.1016/0024-3205(84)90515-0 |
0.343 |
|
| 1983 |
Pilc A, Rokosz-Pelc A. The attenuation by chronic electroconvulsive treatment of hypothermia induced by histamine H2-receptor stimulants in rats. European Journal of Pharmacology. 88: 255-7. PMID 6221937 DOI: 10.1016/0014-2999(83)90014-6 |
0.423 |
|
| 1983 |
Vetulani J, Szpak J, Pilc A. Spaced electroconvulsive treatment: effects on responses associated with alpha 2- and 5-HT2-receptors. The Journal of Pharmacy and Pharmacology. 35: 326-8. PMID 6134806 DOI: 10.1111/J.2042-7158.1983.Tb02946.X |
0.311 |
|
| 1982 |
Golembiowska-Nikitin K, Pilc A, Vetulani J. Cataleptogenic doses of morphine suppress 3H-spiroperidol binding to striatal membranes. Naunyn-Schmiedeberg's Archives of Pharmacology. 319: 140-1. PMID 7202125 DOI: 10.1007/Bf00503927 |
0.416 |
|
| 1982 |
Pilc A, Rogóz Z, Skuza G. Histidine-induced bizarre behaviour in rats: the possible involvement of central cholinergic system. Neuropharmacology. 21: 781-5. PMID 7121750 DOI: 10.1016/0028-3908(82)90065-X |
0.427 |
|
| 1982 |
Pilc A, Vetulani J. Depression by chronic electroconvulsive treatment of clonidine hypotherma and [3H]clonidine binding to rat cortical membranes. European Journal of Pharmacology. 80: 109-13. PMID 6284527 DOI: 10.1016/0014-2999(82)90184-4 |
0.31 |
|
| 1982 |
Pilc A, Vetulani J. Attenuation by chronic imipramine treatment of [3H]clonidine binding to cortical membranes and of clonidine-induced hypothermia: the influence of central chemosympathectomy. Brain Research. 238: 499-504. PMID 6284303 DOI: 10.1016/0006-8993(82)90131-7 |
0.327 |
|
| 1982 |
Vetulani J, Pilc A. Postdecapitation convulsions in the rat measured with an Animex motility meter: relation to central alpha-adrenoceptors. European Journal of Pharmacology. 85: 269-75. PMID 6129989 DOI: 10.1016/0014-2999(82)90214-X |
0.338 |
|
| 1981 |
Vetulani J, Lebrecht U, Pilc A. Enhancement of responsiveness of the central serotonergic system and serotonin-2 receptor density in rat frontal cortex by electroconvulsive treatment. European Journal of Pharmacology. 76: 81-5. PMID 7318923 DOI: 10.1016/0014-2999(81)90012-1 |
0.425 |
|
| 1980 |
Pilc A, Nowak JZ. The influence of 4-methylhistamine, an agonist of histamine H2 receptors on body temperature in rats. Neuropharmacology. 19: 773-5. PMID 6448357 DOI: 10.1016/0028-3908(80)90069-6 |
0.39 |
|
| 1980 |
Pilc A, Rogóz Z, Byrska B. Some central effects of impromidine, a potent agonist of histamine H2 receptors. Neuropharmacology. 19: 947-50. PMID 6158709 DOI: 10.1016/0028-3908(80)90003-9 |
0.408 |
|
| 1980 |
Golembiowska-Nikitin K, Pilc A, Vetulani J. Opiates and specific receptor binding of [3H]clonidine. The Journal of Pharmacy and Pharmacology. 32: 70-1. PMID 6102136 DOI: 10.1111/J.2042-7158.1980.Tb12852.X |
0.354 |
|
| 1979 |
Pilc A, Gołembiowska-Nikitin K, Vetulani J. Negligible binding of 3H-clonidine to histamine H2 receptor. European Journal of Pharmacology. 56: 177-8. PMID 467507 DOI: 10.1016/0014-2999(79)90450-3 |
0.314 |
|
| 1979 |
Pilc A, Nowak JZ. Influence of histamine on the serotonergic system of rat brain. European Journal of Pharmacology. 55: 269-72. PMID 456425 DOI: 10.1016/0014-2999(79)90194-8 |
0.372 |
|
| 1979 |
Nowak JZ, Pilc A. The influence of histamine H2-receptor antagonists on monoaminergic systems in rat brain [proceedings]. Agents and Actions. 9: 88-9. PMID 37729 DOI: 10.1007/Bf02024133 |
0.393 |
|
| 1978 |
Nowak JZ, Pilc A, Maśliński C. An interaction of histamine H2-receptor antagonists with the noradrenergic system in rat brain. European Journal of Pharmacology. 51: 71-5. PMID 29763 DOI: 10.1016/0014-2999(78)90063-8 |
0.392 |
|
| 1977 |
Nowak JZ, Pilc A. Direct or indirect action of histamine on dopamine metabolism in the rat striatum? European Journal of Pharmacology. 46: 171-5. PMID 590328 DOI: 10.1016/0014-2999(77)90253-9 |
0.398 |
|
| 1977 |
Nowak JZ, Pilc A, Lebrecht U, Maśliński C. Does histamine interact with cholinergic neurones in its cataleptogenic action in the rat Neuropharmacology. 16: 841-847. DOI: 10.1016/0028-3908(77)90146-0 |
0.383 |
|
| Show low-probability matches. |